50817-44-2Relevant articles and documents
Preparation of the Serotonin Transporter PET Radiotracer 2-({2-[(Dimethylamino)methyl]phenyl}thio)-5-[18 F]fluoroaniline (4-[18 F]ADAM): Probing Synthetic and Radiosynthetic Methods
Aigbirhio, Franklin I.,Milicevic Sephton, Selena,Thompson, Stephen,Zhou, Xiaoyun
supporting information, p. 4374 - 4384 (2019/11/21)
Serotonin transporters (SERTs) are involved in regulating the concentration of synaptic serotonin and present a good target for many neurologic and psychiatric disorder drugs. Positron-emission tomography (PET) is a valuable tool in both diagnosis and mon
NOVEL SULFONAMIDE COMPOUNDS
-
Page/Page column 8, (2009/12/02)
The invention relates to novel sulfonamide compounds and their use as orexin receptor antagonists.
Model systems for flavoenzyme activity: An investigation of the role functionality attached to the C(7) position of the flavin unit has on redox and molecular recognition properties
Caldwell, Stuart T.,Farrugia, Louis J.,Hewage, Shanika Gunatilaka,Kryvokhyzha, Nadiya,Rotello, Vincent M.,Cooke, Graeme
supporting information; experimental part, p. 1350 - 1352 (2009/07/10)
We describe the role functionality attached to the C(7) position of a family of flavin derivatives has in tuning their redox and recognition properties and the subsequent exploitation of two of these derivatives as a three-component electrochemically cont
NOVEL SULFONAMIDE COMPOUNDS
-
Page/Page column 19-20, (2008/06/13)
The invention relates to sulfonamide compounds of formula (I), where A, B, R3 and R4 are as defined in the claims, and their use as orexin receptor antagonists in the prevention and treatment of eating and drinking disorders, all types of sleep disorders, all kinds of cognitive dysfunctions in the healthy population and psychiatric and neurologic disorders. Formula (I).